Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 30.80
-0.20 (-0.65%)
Sep 10, 2025, 12:40 PM CST
Sofiva Genomics Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 406.32 | 453.31 | 466.8 | 495.78 | 508.42 | 488.87 | Upgrade | |
Revenue Growth (YoY) | -15.05% | -2.89% | -5.85% | -2.49% | 4.00% | -4.04% | Upgrade |
Cost of Revenue | 299.82 | 317.65 | 336.89 | 346.79 | 331.6 | 336.12 | Upgrade |
Gross Profit | 106.51 | 135.66 | 129.91 | 148.99 | 176.81 | 152.74 | Upgrade |
Selling, General & Admin | 131.04 | 129.06 | 136.15 | 135.35 | 130.91 | 122.54 | Upgrade |
Research & Development | 10.37 | 9.98 | 9.64 | 10.34 | 10.8 | 9.62 | Upgrade |
Operating Expenses | 141.41 | 139.03 | 145.79 | 145.2 | 141.57 | 131.82 | Upgrade |
Operating Income | -34.9 | -3.37 | -15.88 | 3.79 | 35.24 | 20.92 | Upgrade |
Interest Expense | -1.02 | -1.11 | -1.29 | -1.49 | -1.74 | -1.97 | Upgrade |
Interest & Investment Income | 1.4 | 1.4 | 1.46 | 0.67 | 0.35 | 0.41 | Upgrade |
Earnings From Equity Investments | 25.67 | 25.35 | 23.67 | 41.9 | 31.05 | 17.5 | Upgrade |
Other Non Operating Income (Expenses) | 0.65 | 1.35 | 0.95 | 2.48 | -1.2 | 0.41 | Upgrade |
EBT Excluding Unusual Items | -8.2 | 23.62 | 8.9 | 47.35 | 63.69 | 37.28 | Upgrade |
Pretax Income | -8.2 | 23.62 | 8.9 | 47.35 | 63.69 | 37.28 | Upgrade |
Income Tax Expense | -1.49 | 4.49 | -3.02 | 4.2 | 6.92 | 3.07 | Upgrade |
Earnings From Continuing Operations | -6.71 | 19.13 | 11.92 | 43.15 | 56.77 | 34.21 | Upgrade |
Minority Interest in Earnings | -0.55 | -0.7 | -0.4 | -0.38 | 0.21 | 0.41 | Upgrade |
Net Income | -7.27 | 18.43 | 11.53 | 42.78 | 56.98 | 34.62 | Upgrade |
Net Income to Common | -7.27 | 18.43 | 11.53 | 42.78 | 56.98 | 34.62 | Upgrade |
Net Income Growth | - | 59.88% | -73.05% | -24.92% | 64.58% | -44.76% | Upgrade |
Shares Outstanding (Basic) | 22 | 21 | 21 | 21 | 21 | 21 | Upgrade |
Shares Outstanding (Diluted) | 22 | 22 | 21 | 21 | 21 | 21 | Upgrade |
Shares Change (YoY) | 0.42% | 1.28% | -0.04% | 0.40% | -0.43% | -0.34% | Upgrade |
EPS (Basic) | -0.34 | 0.86 | 0.54 | 2.00 | 2.68 | 1.63 | Upgrade |
EPS (Diluted) | -0.34 | 0.85 | 0.54 | 2.00 | 2.68 | 1.62 | Upgrade |
EPS Growth | - | 57.52% | -73.02% | -25.30% | 65.26% | -44.52% | Upgrade |
Free Cash Flow | 20.6 | 17.77 | 2.69 | -16.4 | 71.91 | 45.35 | Upgrade |
Free Cash Flow Per Share | 0.96 | 0.82 | 0.13 | -0.77 | 3.38 | 2.12 | Upgrade |
Dividend Per Share | - | 0.300 | 0.200 | 1.000 | 2.000 | 1.400 | Upgrade |
Dividend Growth | - | 50.00% | -80.00% | -50.00% | 42.86% | -46.15% | Upgrade |
Gross Margin | 26.21% | 29.93% | 27.83% | 30.05% | 34.78% | 31.24% | Upgrade |
Operating Margin | -8.59% | -0.74% | -3.40% | 0.76% | 6.93% | 4.28% | Upgrade |
Profit Margin | -1.79% | 4.07% | 2.47% | 8.63% | 11.21% | 7.08% | Upgrade |
Free Cash Flow Margin | 5.07% | 3.92% | 0.58% | -3.31% | 14.14% | 9.28% | Upgrade |
EBITDA | -7.94 | 22.46 | 10.21 | 29.85 | 60.4 | 52.19 | Upgrade |
EBITDA Margin | -1.95% | 4.96% | 2.19% | 6.02% | 11.88% | 10.67% | Upgrade |
D&A For EBITDA | 26.96 | 25.83 | 26.1 | 26.06 | 25.16 | 31.26 | Upgrade |
EBIT | -34.9 | -3.37 | -15.88 | 3.79 | 35.24 | 20.92 | Upgrade |
EBIT Margin | -8.59% | -0.74% | -3.40% | 0.76% | 6.93% | 4.28% | Upgrade |
Effective Tax Rate | - | 19.00% | - | 8.86% | 10.87% | 8.24% | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.